citalopram has been researched along with asenapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björkholm, C; Frånberg, O; Jardemark, K; Konradsson-Geuken, Å; Malmerfelt, A; Marcus, MM; Schilström, B; Svensson, TH | 1 |
| Asada, R; Hori, H; Kawasaki, H; Ogushi, Y | 1 |
2 other study(ies) available for citalopram and asenapine
| Article | Year |
|---|---|
Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
Topics: Animals; Antipsychotic Agents; Benzazepines; Bicuculline; Biogenic Monoamines; Citalopram; Dibenzocycloheptenes; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Agents; Excitatory Postsynaptic Potentials; GABA-A Receptor Antagonists; Glutamic Acid; Heterocyclic Compounds, 4 or More Rings; Male; Neurons; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Time Factors | 2014 |
Successful treatment for major depressive disorder with psychotic features with addition of asenapine on escitalopram.
Topics: Antipsychotic Agents; Citalopram; Depressive Disorder, Major; Dibenzocycloheptenes; Double-Blind Method; Escitalopram; Humans; Treatment Outcome | 2022 |